EU rolls out plan to address bottlenecks in healthcare

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

European Commission wants to speed up biotech, fix device bottlenecks and cut heart disease, while keeping Europe competitive in global race.

The European Commission has unveiled a broad, deliberately pro-innovation package designed to make the EU’s health sector sharper on three fronts: more innovative, more competitive, and more shock-resistant – while still grappling with the public health problems that keep ministers up at night [1].

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Kyle Umipig

Kyle has nine years of editorial writing experience. They have been following the longevity sector since 2022, focusing on research, emerging tech, and the companies shaping the future of aging and age-related health.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Novartis exits a BioArctic deal worth up to $802m

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE